News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CARsgen Therapeutics-B (02171.HK) Abstracts of CT0596 and CT1190B Studies Selected for Poster Presentation at EHA Annual Meeting
CARsgen Therapeutics-B (02171.HK) announced that the abstract of the investigator-initiated trial (IIT) results for CT0596 in the treatment of relapsed/refractory multiple myeloma/...
Reset
Send
The window will close in 5 seconds
CARsgen Therapeutics-B (02171.HK) Abstracts of CT0596 and CT1190B Studies Selected for Poster Presentation at EHA Annual Meeting
Close
Recommend
2
Positive
2
Negative
3
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

CARsgen Therapeutics-B (02171.HK)  -0.280 (-1.687%)    Short selling $16.64M; Ratio 17.923%   announced that the abstract of the investigator-initiated trial (IIT) results for CT0596 in the treatment of relapsed/refractory multiple myeloma/plasma cell leukemia, and the abstract of the IIT results for CT1190B in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma, have been accepted for poster presentation at the 2026 European Hematology Association (EHA) Annual Meeting. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-05 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.